Posts in the “Biomarkers Biomarkers” category:

Advancing the development of new “targeted drug therapies” by enhancing the science of biomarkers

Posted by Samantha Powell on October 3rd, 2014 |

A key area of new drug development lies in the field of targeted therapies, sometimes called “personalized medicines,” which are drugs tailored to the genetic makeup of individual patients. These drugs are called targeted therapy because health care professionals can use clinical test results from a patient to select a specific drug that has a […]

Treatment For Lung Cancer May Depend On Your DNA

Posted by Samantha Powell on September 16th, 2014 |

The Northside Hospital Cancer Institute (NHCI), Atlanta, has announced it will participate in a unique National Cancer Institute clinical collaboration to treat lung cancer based on a patient’s genetic profile, becoming the first to offer the clinical trial known as Lung-MAP. The study is a multi-drug, multi-arm, biomarker-driven clinical trial for patients with advanced squamous […]

Lifestyle and genetics strongly impact biomarkers for inflammation and cancer

Posted by Samantha Powell on September 16th, 2014 |

Genetics and lifestyle are determining factors for protein levels in the bloodstream, according to a new study. This discovery greatly influences the possibilities for using more biomarkers to identify disease. This finding came from a large-scale study of the significance of genetic, clinical, and lifestyle factors on protein levels in the bloodstream. It was conducted […]

UNC researchers mapping cancer genes

Posted by Samantha Powell on August 29th, 2014 |

Cancer researchers know that the key to beating the disease lies in discovering its many genetic identities. Now, researchers in the genome sequencing lab at the University of North Carolina at Chapel Hill have the tools to uncover a tumor’s specific genetic identity. The work is part of the Cancer Genome Atlas Study. By 2008, […]

Ambitious ‘Lung-MAP’ Trial Aims to Evaluate Biomarkers and New Drugs in Squamous Cell Lung Cancer

Posted by Samantha Powell on June 23rd, 2014 |

This month, the National Cancer Institute (NCI), along with the FDA, the Southwest Oncology Group (SWOG), several private foundations and five pharmaceutical companies, launched a prospective, biomarker-driven study of new drugs for squamous cell lung cancer. The Lung-MAP trial is remarkable for its collaborative nature, and scope. The study will identify “actionable” molecular abnormalities in […]

Amgen Joins National Cancer Institute, Other Companies On Lung-MAP Project

Posted by Samantha Powell on June 16th, 2014 |

Amgen announced that it will collaborate with the National Cancer Institute and other public and private sector partners on the Lung Master Protocol (Lung-MAP), a clinical trial program that will use biomarker-driven research and genomic profiling to match squamous cell lung cancer patients to investigational treatments based on their individual cancer profiles. In the U.S., […]

Lung-MAP trial launched, matching patients to treatments based on tumor profiles

Posted by Samantha Powell on June 16th, 2014 |

A phase II/III trial using genomic profiling to match patients with investigational treatments began recruiting patients with advanced squamous cell lung cancer on June 16, 2014. The Lung-MAP (Lung Cancer Master Protocol) trial is a public-private collaboration among the National Cancer Institute (NCI), SWOG Cancer Research, Friends of Cancer Research, the Foundation for the National […]

Bonnie J. Addario Lung Cancer Foundation Joins Lung-MAP, Collaborative Group Multi-drug, Biomarker-driven Clinical Trial for Lung Cancer

Posted by Samantha Powell on June 16th, 2014 |

For further information or inquiries, please contact: Matt Notley Perry Communications matt@perrycom.com Bonnie J. Addario Lung Cancer Foundation Joins Lung-MAP, Collaborative Group Multi-drug, Biomarker-driven Clinical Trial for Lung Cancer Innovative approach to clinical testing to improve access and ease burden on researchers SAN CARLOS, CA (May 19, 2014) — The Bonnie J Addario Lung Cancer […]

Simple Blood Test to Spot Early Lung Cancer Getting Closer

Posted by Samantha Powell on April 6th, 2014 |

Date: 4/6/14 Outlet Full Name: NPR Author: Richard Harris http://www.npr.org/blogs/health/2014/04/06/299179255/simple-blood-test-to-spot-early-lung-cancer-getting-closer One of these days, there could well be a simple blood test that can help diagnose and track cancers. We aren’t there yet, but a burst of research in this area shows we are getting a lot closer. In the latest of these studies, scientists […]

Team Identifies Novel Biomarker for Head and Neck Cancer, Non- Small Cell Lung Cancer

Posted by Samantha Powell on April 2nd, 2014 |

Date: 4/2/14 Outlet Full Name: Science Codex Author: No author http://www.sciencecodex.com/team_identifies_novel_biomarker_for_head_and_neck_cancer_nonsmall_cell_lung_cancer-131018 A team led by a scientist from the Florida campus of The Scripps Research Institute (TSRI) has identified a new biomarker linked to better outcomes of patients with head and neck cancers and non-small cell lung cancer. The work could help scientists develop new […]